10% Discount Pharmaceuticals 2012 || Coagulation Disorders Market to 2017 - Hemophilia A

Document Sample
10% Discount Pharmaceuticals 2012 || Coagulation Disorders Market to 2017 - Hemophilia A Powered By Docstoc
					        Aarkstore.com announces 10% Discount on this report till 6th April
2012

Coagulation Disorders Market to 2017 - Hemophilia A, the
Largest Segment, to Witness a Decline in Growth Rate due to
Patent Expiries and Weak Pipeline

http://www.aarkstore.com/reports/Coagulation-Disorders-Market-to-2017-
Hemophilia-A-the-Largest-Segment-to-Witness-a-Decline-in-Growth-Rate-
due-to-Patent-Expiries-and-Weak-Pipeline-155658.html




Discount offer till 6th April 2012



Summary

Company, the leading business intelligence provider, has released its latest research,
“Coagulation Disorders Market to 2017 - Hemophilia A, the Largest Segment, to
Witness a Decline in Growth Rate due to Patent Expiries and Weak Pipeline”,
provides in-depth analysis of unmet needs, drivers and barriers that impact the
global coagulation disorders market. The report analyzes the markets for
coagulation disorders in the US, the top five countries in Europe (the UK, Germany,
France, Italy and Spain) and Japan. Market size, annual cost of therapy and
treatment usage patterns are forecast until 2016 for the key geographies, as well as
the leading therapeutic segments which includes hemophilia A, hemophilia B and
von Willebrand Disease. Furthermore, the report provides competitive
benchmarking for the leading companies and analyzes the mergers, acquisitions and
licensing agreements that shape the global coagulation disorders market.

Scope

The scope of this report includes -
- Annualized market data for the coagulation disorders market from 2002 to 2010,
forecast forward to 2017.
- Analysis of the leading therapeutic segments, including hemophilia A, hemophilia
B, and von Willebrand’s disease (vWD).



Reasons to buy

The report will enhance your decision making capability. It will allow you to -
- Align your product portfolio to the markets with high growth potential.
- Develop market-entry and market expansion strategies by identifying the leading
therapeutic segments and geographic markets poised for strong growth.

Table of Contents :

1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 9
2.1 GBI Research Report Guidance 9
3 Coagulation Disorders Therapeutics Market: Market Overview 10
3.1 Introduction 10
3.2 Revenue Forecasts for the Global Coagulation Disorders Market 11
3.2.1 Revenue 11
3.2.2 Annual Cost of Therapy 12
3.2.3 Treatment Usage Pattern 13
3.3 Coagulation Disorders Market Drivers 19
3.3.1 Steady Increase in the Prevalence Population, Particularly in the Top Five
Countries in Europe 19
3.3.2 Rapid Uptake of Recombinant Products due to Better Efficacy, Safety and
Convenient Dosing 19
3.3.3 Increase in the Prescription Population due to Patent Expiries of Expensive
Biologic Drugs, Making Them More Affordable 20
3.4 Coagulation Disorders Market Restraints 21
3.4.1 Low Diagnosed Population as Mild and Moderate Forms of Coagulation
Disorders Go Undiagnosed 21
3.4.2 Patent Expiries of Major Blockbusters Including Kogenate FS, BeneFIX,
NovoSeven, and ReFacto Pose a Threat to Leading Players in the Market 21
3.4.3 Sluggish Growth in the Annual Cost of Therapy for Coagulation Disorders is
Expected to Drive Down the Growth Rate 21

For more related Reports Plz follow The link:
Gastrointestinal Disorder Therapeutics Market to 2017 - Crohns Disease and
Irritable Bowel Syndrome Markets Show Strongest Growth

Respiratory Disorders Therapeutics Market to 2017 - Novel Pipeline Molecules such
as VX-770 and pirfenidone May Offset Negative Effect of Patent Expiries

Manufacturing of Vaccines - Cell Culture Technology Gradually Replacing Egg-Based
Manufacturing

Immunoglobulins Market to 2017 - Off-Label Usage and Treatment of Primary
Immunodeficiency Diseases and Neurological Disorders Stimulate Market Growth




For More details Plz do contact :

Aarkstore Enterprise

Phone:08149852585

Email: enquiry@aarkstore.com/

URL:www.aarkstore.com/

				
DOCUMENT INFO
Shared By:
Categories:
Stats:
views:6
posted:4/3/2012
language:
pages:3
Description: the report provides competitive benchmarking for the leading companies and analyzes the mergers, acquisitions and licensing agreements that shape the global coagulation disorders market.